Source: Annual Congress 2004 - Animal models of allergic airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ota, H. Sagara, G. Cheng, K. Akimoto, K. Sugiyama, T. Okada, A. Nakao, T. Fukuda (Mibu, Kofu, Japan). Decreased Smad7 expression in the airways of a mouse model of chronic asthma. Eur Respir J 2004; 24: Suppl. 48, 4023

Member's Comments

No comment yet.

Related content which might interest you: MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Reduced bronchial epithelial Smad7 protein expression in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005 ST2 gene knockout attenuates allergic airways disease Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007 Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002 Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Murine models of asthma Source: Eur Respir J 2003; 22: 374-382 Year: 2003 Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006